Learn

Blog

Re:search – The Hidden Risks of Long-Term Proton Pump Inhibitor (PPI) Use: A Call for Root-Cause Solutions

Long-term PPI use carries serious risks—from nutrient deficiencies and cognitive decline to microbiome disruption—making root-cause alternatives like Re:flux worth considering.
Written by the Re:Your Gut Team
12 min read, Updated March 2026

Re:search – The Hidden Risks of Long-Term PPI Useexamines the growing body of evidence linking chronic proton pump inhibitor use to serious health consequences—including nutrient deficiencies, cognitive decline, kidney disease, and gut microbiome disruption. It makes the case for shifting toward root-cause therapies like polyphenol-based Re:flux that restore natural digestive function rather than suppress it indefinitely.
Re:search – The Hidden Risks of Long-Term Proton Pump Inhibitor (PPI) Use: A Call for Root-Cause Solutions

Key Takeaways
  • PPIs are effective for short-term acid relief but long-term use is linked to a range of serious health risks.
  • Chronic PPI use can cause nutrient deficiencies in vitamin B12, calcium, magnesium, and iron, potentially leading to anemia, bone fractures, and neurological issues.
  • Long-term PPI use has been associated with increased risk of cognitive decline, chronic kidney disease, and cardiovascular problems.
  • PPIs disrupt the gut microbiome by reducing the acid barrier, increasing susceptibility to infections like C. difficile and promoting SIBO.
  • Root-cause therapies that support motility, sphincter function, and mucosal healing—such as polyphenol-based Re:flux—offer a safer long-term alternative to acid suppression.

Rebound Hyperacidity

Upon withdrawal of PPIs, patients often experience rebound acid hypersecretion, a transient surge in acid production that can intensify symptoms (1). This creates a dependency loop, making long-term discontinuation challenging.

Nutrient Deficiencies

Prolonged PPI use has been linked to malabsorption of vitamin B12, calcium, magnesium, and iron (2,3). These deficiencies may contribute to anemia, bone fractures, and neurological dysfunction.

Cognitive Decline

Several population-based studies have suggested a correlation between long-term PPI use and increased risk of dementia, with proposed mechanisms including vitamin B12 deficiency and altered central nervous system pH (4,5).

Kidney and Cardiovascular Risk

Long-term use of PPIs has also been associated with chronic kidney disease, acute interstitial nephritis, and increased cardiovascular risk (6,7).

Microbiome Disruption

PPIs alter the gut’s natural acid barrier, increasing susceptibility to infections such as Clostridium difficile and promoting small intestinal bacterial overgrowth (SIBO) (8).

Gastric Atrophy and Hypergastrinemia

Acid suppression can lead to compensatory hypergastrinemia and changes in the gastric mucosa, including fundic gland polyps and atrophic gastritis (9).

Drug Interactions

By affecting cytochrome P450 enzymes, PPIs can interfere with the metabolism of common medications, including clopidogrel, warfarin, and certain antifungals (10).

Discussion

While PPIs remain appropriate for acute symptom relief and healing of esophageal erosions, their long-term use should be reconsidered. Many symptoms attributed to acid excess are better understood as dysfunctions of motility, mucosal protection, or esophageal sphincter tone.

Conclusion

The rising concerns around chronic PPI use highlight the need for safer, more holistic approaches. Emerging therapies—such as polyphenol-based combinations that support motility, sphincter function, and mucosal healing—offer a promising path forward. A shift toward root-cause resolution, rather than perpetual suppression, may benefit millions.

References

  1. Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80–7.
  2. Hirschowitz BI, Worthington J, Mohnen J. Vitamin B12 deficiency in hypersecretors during long-term omeprazole therapy. Aliment Pharmacol Ther. 2008;27(11):1110–21.
  3. den Elzen WPJ, Groeneveld Y, de Ruijter W, Souverijn JH, le Cessie S, Assendelft WJJ, et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27(6):491–7.
  4. Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol. 2016;73(4):410–6.
  5. Tai SY, Chien CY, Wu DC, Lin KD, Ho BL, Chang YH, et al. Risk of dementia from proton pump inhibitor use in Asian population: a nationwide cohort study in Taiwan. PLoS One. 2017;12(2):e0171006.
  6. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238–46.
  7. Charlot M, Ahlehoff O, Norgaard ML, Jørgensen CH, Sørensen R, Abildstrøm SZ, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010;153(6):378–86.
  8. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8(6):504–8.
  9. Waldum HL, Sagatun L, Mjønes P. Gastric acid secretion: regulation and role in Helicobacter pylori-associated disease. Scand J Gastroenterol. 2015;50(8):933–9.
  10. Zhou SF, Xue CC, Yu XQ, Li C, Wang G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007;29(6):687–710.

On This Page

    Because Reflux Has A Cause.

    Support healthy digestive function, not just temporary relief

    Shop Now

    Related Post

    The AIP Diet: The Best Foods to Eat for Autoimmune Diseases
    How to Keep Your Gut Healthy While Traveling
    How to Get Rid of Bloating
    Does Constipation Cause Dementia?

    Dr. Ken Brown, MD

    Board-Certified Gastroenterologist
    Creator of Atrantil · Host, Gut Check Project

    Dr. Brown has practiced gastroenterology for over 20 years in Plano, TX. He developed Atrantil to bridge the gap between natural and medical science, and educates millions through the Gut Check Project podcast.